<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drugDebug/PMC7120516/results/search/funder/results.xml">
  <result pre="al. 2010). Novel genotyping strategies are emerging on a regular" exact="basis" post="using a variety of techniques designed to increase the"/>
  <result pre="of drug resistance phenotypes for HIV-1 protease on a patient-by-patient" exact="basis" post="(Shenderovich et al. 2003). The interaction and movements of"/>
  <result pre="and specificity for predicting drug resistance phenotypes on a patient-by-patient" exact="basis" post="for various Food and Drug Administration (FDA; http://www.fda.gov)-approved drugs,"/>
  <result pre="du Praticien2000501066107010905090 DoyleSESchreckhiseHKhuu-DuongKet al.Interleukin-29 uses a type 1 interferon- like" exact="program" post="to promote antiviral responses in human hepatocytesHepatology20064489690617006906 Dragsted U,"/>
 </snippets>
</snippetsTree>
